Zosano Pharma Corporation (ZSAN)

Trade ZSAN now with
4/11/2022 8:10:39 AM Zosano Pharma Board Approves 1-for-35 Reverse Stock Split
7/20/2021 8:36:17 AM Zosano Pharma Announces Issuance Of U.S. Patent For Method Of Achieving Therapeutic Levels With M207 For Migraine
2/22/2021 8:43:42 AM Zosano Pharma Confirms NDA Resubmission Strategy Following Type A Meeting Minutes From FDA
2/1/2021 8:10:22 AM Zosano Pharma Reports NDA Resubmission Plans Following Type A Meeting With FDA